Industry

OSLO, Norway–(BUSINESS WIRE)–#KavliPrize2022–The Norwegian Academy of Science and Letters today announced the 2022 Kavli Prize Laureates in the fields of astrophysics, nanoscience, and neuroscience. Eleven scientists from six countries are honored for their research that has transformed our understanding of the big, the small and the complex. The laureates in each field will share $1 … [Read more…]

LIVONIA, Mich.–(BUSINESS WIRE)–#healthcare—MedCerts, a leader in online healthcare and IT certification training, has teamed with Goshen Health to address vacancies and shortages of their frontline healthcare workers. Through this train-and-hire partnership, MedCerts — a Stride, Inc. company (NYSE: LRN) — will support the recruitment and clinical training for Medical Assistants and Medical Billing positions at … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Gene Synthesis Market By Method, By Service Type, By Application, By End User, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The Global Gene Synthesis Market size is expected to reach $5.2 billion by 2027, rising at a market growth of 17.9% CAGR during … [Read more…]

Pavilion features 11 innovative companies displaying products for cycling, camping, hiking, swimming and much more DENVER, Colorado,–(BUSINESS WIRE)–#ASUS—Outdoor Retailer Summer Show – With the theme “Explore Every Terrain,” the Taiwan External Trade Development Council (TAITRA), Taiwan’s foremost trade promotion organization, is set to exhibit a multitude of fun and innovative outdoor products at the 2022 … [Read more…]

CINCINNATI–(BUSINESS WIRE)–The U. S. Environmental Protection Agency (EPA) has registered Microban 24 Multi-Purpose Cleaner (EPA Reg No. 4091-21-3573) to keep killing 99.9% of bacteria & viruses that cause the flu and COVID-19, for up to 24 hours, even when the surface is touched or contacted multiple times1. While it had previously been registered by the … [Read more…]

NEW HAVEN, Conn.–(BUSINESS WIRE)–Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: Jefferies Healthcare Conference in New York, NY on Wednesday, June 8, 2022 at 10:30 a.m. ET. JMP … [Read more…]

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that management will participate in two upcoming investor conferences in June: Jefferies Healthcare Conference Format: Presentation Presentation Date/Time: Wednesday, June 8, 2022 at 4:30 … [Read more…]

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, announced the appointment of Deborah Yount as Chief Human Resources Officer, effective today. Ms. Yount will have responsibility for global Human Resources activities. “We are excited to have … [Read more…]

Trial evaluating AB248, a CD8+ T cell cis-targeted IL-2 immunotherapy, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, aims to address unmet need for patients who are non-responsive to previous anti-PD-1 therapy or enhance current standard of care in an early line of therapy SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced that Michael Gilman, Ph.D., Chief Executive Officer, will present a corporate overview at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 3:30 p.m. ET in New York. About Arrakis … [Read more…]